Group 1 - The enthusiasm of private equity institutions for researching A-share market has significantly increased, with 923 private equity institutions conducting research on 209 A-share listed companies in March, marking a 107.38% increase from January and a 10.02% increase from February [1] - The main drivers behind this research surge include the recovery of the A-share market boosting investor confidence, ongoing market interest in technology sectors like artificial intelligence and semiconductors, and the desire to identify structural opportunities amid market differentiation [1] - Guangdong Zhengyuan Private Fund Management Company led the research frequency with 96 instances, focusing on seven listed companies that saw stock price increases exceeding 20% in March [1] Group 2 - In March, the machinery equipment, electronics, and pharmaceutical biology sectors were the primary focus of private equity research, with machinery equipment companies receiving 259 research instances, electronics 258, and pharmaceutical biology 243 [2] - The technology sector is becoming a key investment area for private equity institutions, while the pharmaceutical sector, particularly innovative Chinese drug companies, is showing investment value after a long adjustment period [2] - The pharmaceutical sector is currently at a historical low in valuation, with institutional allocation below historical averages, indicating a high safety margin and growth potential [2]
私募机构调研热情不断攀升
Zheng Quan Ri Bao·2025-04-06 16:15